Gamlen Tablet Press produces model data
Used to demonstrate the use of statistical methodologies of Principal Components Analysis and Design of Experiments.
Gamlen R-series tablet presses have been used to demonstrate the use of statistical methodologies of Principal Components Analysis (PCA) and Design of Experiments (DoE) in a workshop on understanding and optimising chemical processes.
Delivered by the Industrial Statistics Research Unit (ISRU), Newcastle University and the Department of Chemistry, Durham University, the Gamlen R-series (formally the GTP-1) was used during practical sessions to produce tabletability data.
Professor Patrick Steel, Durham University, explains: “As part of the course we conducted a laboratory experiment. One of the problems in creating the course is designing an experiment that will deliver reproducible results so that the students can generate models from the data.
We were keen to choose a chemistry orientated experiment — with tablet making there are a number of variables that can be controlled such as the speed of the press, the composition of the tablet and the compaction force. These are all variables that we could adjust fairly easily in the lab experiment. During trialling, we quickly found that the Gamlen Tablet Press generated very consistent results and allowed control of variables which made the Gamlen R-series an ideal tool to teach the important course principles.
Experiments were conducted repeatedly over the two consecutive days of the course and were found to generate the same data. To get our course objectives across, it was imperative that we could rely on the experiment to work and the Gamlen Tablet Press gave us that reproducibility. If errors occurred, something had gone wrong in the experiment itsel; i.e., errors were errors — not random noise in the data. This was important as it supported the material we were teaching.”
Gamlen R-series tablet presses are easy to use, with novice users requiring as little as 30 minutes training to be able to control the basic functions of the instruments. Ideal for the academic research market, Gamlen R-series machines are entirely computer-controlled, portable, laboratory instruments that enable understanding and experimentation with the relationship between the properties of substances, the composition of a formulation and the manufacturing process.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance